D-0677-2026 Class II Ongoing
FDA drug recall D-0677-2026 was initiated by Padagis US LLC on Jun 23, 2026 and is designated Class II. Reason for recall: Subpotent Drug: Low out of specification assay results performed during long-term stability testing. The recall status is ongoing. Affected quantity: 180,936 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 22, 2026
- Initiation Date
- Jun 23, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 180,936 tubes
Product description
Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
Reason for recall
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Distribution pattern
USA Nationwide
Code information
Lot #: 205060, Exp 09/30/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0677-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026